Clinical Trial Update: SERS-Based Serum Molecular Spectral Screening for Hematogenous Metastasis

View source ↗

Summary

A clinical trial update on a SERS-based serum molecular spectral screening method intended to detect hematogenous metastasis in lung cancer patients. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Fuzhou General Hospital | Conditions: Lung Cancers | Status: NOT_YET_RECRUITING